109 related articles for article (PubMed ID: 12890805)
21. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas.
Schneider-Stock R; Ziegeler A; Haeckel C; Franke DS; Rys J; Roessner A
Clin Cancer Res; 1999 Oct; 5(10):2830-5. PubMed ID: 10537349
[TBL] [Abstract][Full Text] [Related]
23. The usefulness of immunohistochemistry for phosphohistone H3 as a prognostic factor in myxoid liposarcoma.
Takazawa A; Yoshimura Y; Okamoto M; Tanaka A; Kito M; Aoki K; Uehara T; Takahashi J; Kato H; Nakayama J
Sci Rep; 2023 Mar; 13(1):4733. PubMed ID: 36959285
[TBL] [Abstract][Full Text] [Related]
24. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
25. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.
Dürr HR; Rauh J; Baur-Melnyk A; Knösel T; Lindner L; Roeder F; Jansson V; Klein A
BMC Cancer; 2018 Mar; 18(1):304. PubMed ID: 29558901
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases.
Kilpatrick SE; Doyon J; Choong PF; Sim FH; Nascimento AG
Cancer; 1996 Apr; 77(8):1450-8. PubMed ID: 8608528
[TBL] [Abstract][Full Text] [Related]
27. Medulloblastoma: evaluation of proliferative index by monoclonal antibody Mib-1, its prognostic correlation and therapeutic implications.
Ferrari AF; Araújo MB; Aguiar PH; Plese JP
Arq Neuropsiquiatr; 2003 Sep; 61(3A):547-51. PubMed ID: 14513155
[TBL] [Abstract][Full Text] [Related]
28. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
30. [Pathological significance of NY-ESO-1 expression in the diagnosis of myxoid liposarcoma].
Hei SM; Wei HJ; Chen H; Wang JG
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):225-230. PubMed ID: 30831650
[No Abstract] [Full Text] [Related]
31. MRI characteristics associated with high-grade myxoid liposarcoma.
Gimber LH; Montgomery EA; Morris CD; Krupinski EA; Fayad LM
Clin Radiol; 2017 Jul; 72(7):613.e1-613.e6. PubMed ID: 28256200
[TBL] [Abstract][Full Text] [Related]
32. Prognostic marker analysis in pediatric intracranial ependymomas.
McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
34. A case of myxoid liposarcoma of the breast.
Saito T; Ryu M; Fukumura Y; Asahina M; Arakawa A; Nakai K; Miura H; Saito M; Yao T
Int J Clin Exp Pathol; 2013; 6(7):1432-6. PubMed ID: 23826427
[TBL] [Abstract][Full Text] [Related]
35. Correlation of Ki 67 proliferative index with clinical and pathological features on tissue sections of non Hodgkins lymphoma by immunostaining.
Naz E; Mirza T; Aziz S; Ali A; Danish F
J Pak Med Assoc; 2011 Aug; 61(8):748-52. PubMed ID: 22355994
[TBL] [Abstract][Full Text] [Related]
36. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years.
Knebel C; Lenze U; Pohlig F; Lenze F; Harrasser N; Suren C; Breitenbach J; Rechl H; von Eisenhart-Rothe R; Mühlhofer HML
BMC Cancer; 2017 Jun; 17(1):410. PubMed ID: 28606068
[TBL] [Abstract][Full Text] [Related]
38. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
[TBL] [Abstract][Full Text] [Related]
39. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.
Tajima S; Koda K
Med Mol Morphol; 2017 Jun; 50(2):112-116. PubMed ID: 25986682
[TBL] [Abstract][Full Text] [Related]
40. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
Hoffman A; Ghadimi MP; Demicco EG; Creighton CJ; Torres K; Colombo C; Peng T; Lusby K; Ingram D; Hornick JL; Wang WL; Ravi V; Lazar AJ; Lev D; Pollock RE
Cancer; 2013 May; 119(10):1868-77. PubMed ID: 23401071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]